NEOS THERAPEUTICS INC - COM (NEOS)

CUSIP: 64052L106

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
5,192,185
Share change
-410,322
Total reported value
$30,406,031
Price per share
$5.85
Number of holders
51
Value change
-$2,479,233
Number of buys
24
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 64052L106?
CUSIP 64052L106 identifies NEOS - NEOS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEOS THERAPEUTICS INC - COM (NEOS) as of Q4 2016

As of 31 Dec 2016, NEOS THERAPEUTICS INC - COM (NEOS) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,192,185 shares. The largest 10 holders included FRANKLIN RESOURCES INC, DSC Advisors, L.P., NORTHERN TRUST CORP, BlackRock Fund Advisors, MILLENNIUM MANAGEMENT LLC, DEERFIELD MANAGEMENT CO, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, STATE STREET CORP, and PUTNAM INVESTMENTS LLC. This page lists 51 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.